

Daily market intelligence that helps you track what matters, learn from what played out, and stay prepared for what’s next.
Indian markets are set for a subdued opening as GIFT Nifty trades at 26,054.50, down 79 points from Nifty's Friday close of 26,046.95, signaling weak sentiment ahead of the week's final trading sessions. Global headwinds from Friday's sharp tech selloff in US markets—led by Broadcom's 11.4% plunge on disappointing AI chip guidance—continue to weigh on sentiment, with the S&P 500 falling 1.07% to 6,827.41 and Nasdaq dropping 1.72% to 23,187.69. Asian markets opened lower, with Japan's Nikkei down 1.3% and Hang Seng futures at 25,735, reflecting mounting concerns over tech valuations and AI spending sustainability.
Domestically, Friday's session saw Nifty gain 148.40 points (0.6%) and Sensex rise 449.53 points (0.5%) to close at 85,267.66, supported by late-session buying despite persistent foreign outflows. However, broader indices showed mixed performance—Bank Nifty closed at 59,389.95, while midcap and smallcap indices outperformed with Nifty Midcap 100 up 1.2% and Nifty Smallcap 250 gaining 0.8% during the week. The rupee weakened to 90.3883 against the dollar on December 12, reflecting continued currency pressure.
Key watch factors today include China's November retail sales, fixed asset investment, and industrial production data, which could provide directional cues for Asian markets. Domestically, two IPO listings—Corona Remedies and Prodocs Solutions—are scheduled, alongside allotment for Park Medi World IPO and final subscription day for HRS Aluglaze.
• Dow Jones: Down 0.51% (post record intraday high)
• S&P 500: 6,827.41, down 1.07% from record levels
• Nasdaq Composite: 23,187.69, down 1.72% (Broadcom-led tech rout)
• Nikkei 225: Down 1.3%
• Hang Seng Futures: 25,735 (previous close: 25,976.79)
• S&P/ASX 200: Down 0.66%
• Kospi: Down 2.16%; SK Hynix fell 4%, Samsung Electronics down 3.3%
• GIFT Nifty (07:17 AM IST): 26,054.50, down 79 points from Nifty close
• Previous Close: Nifty 50: 26,046.95 | Sensex: 85,267.66 | Bank Nifty: 59,389.95
• INR/USD: ₹90.3883 (FBIL, December 12)
• Brent Crude: $61.38/bbl (December 15, up 0.42%)
• Gold (MCX): ₹1,17,800/10g (December futures)
Foreign and domestic institutional investors showed divergent trends in the week ending December 12, with DIIs absorbing continued FII selling pressure.
December 12, 2025 (Latest Data):
• FII: Gross Buy: ₹10,979.80 cr | Gross Sell: ₹12,094.02 cr | Net: -₹1,114.22 cr
• DII: Gross Buy: ₹15,616.98 cr | Gross Sell: ₹11,748.04 cr | Net: +₹3,868.94 cr
Weekly Trend (Dec 9-12):
• FII Net Flow: -₹8,546.24 cr (four consecutive days of selling)
• DII Net Flow: +₹18,062.31 cr (strong buying support)
FII outflows intensified through the week, with cumulative selling of ₹8,546.24 crore across four sessions, while DIIs provided robust countervailing support with ₹18,062.31 crore net purchases, preventing sharper market corrections.
Broadcom's revenue guidance triggers valuation reset across tech sector
Broadcom plunged 11.4% on Friday despite beating Q4 earnings, after its AI chip sales outlook fell short of Wall Street's elevated expectations, erasing $219 billion in market cap—the largest single-day loss recorded except for Nvidia, Apple, and Meta. The selloff rippled across global tech markets, with the Nasdaq falling 1.8% and Asian chip stocks extending losses on Monday—South Korea's SK Hynix dropped over 4% and Samsung Electronics fell 3.3%.
Market analysts highlight growing skepticism over whether tech stocks can justify lofty valuations amid aggressive AI infrastructure spending. Nick Twidale of AT Global Markets noted, "This underscores the potential that we could see the AI bubble burst at some point in the near future," warning that Asian markets—heavily reliant on tech manufacturing—appear particularly vulnerable to valuation corrections.
Investor Takeaway: Watch for rotation into cyclicals and defensives; Friday's session already saw this shift in US markets post-tech selloff.
Corona Remedies lists on BSE/NSE today following exceptional 137.04x subscription for its ₹655.37 crore pure OFS issue. The pharma company's price band was ₹1,008-1,062 per share, with allotment finalized on December 11. Proceeds from the OFS go to selling shareholders including Sepia Investments, Anchor Partners, and Sage Investment Trust.
Prodocs Solutions debuts on BSE SME today after its ₹27.60 crore issue (combining fresh issue and OFS) saw 2.66x subscription when it closed on December 10.
Corona Remedies' debut carries high expectations given the massive oversubscription, but investors should watch for realistic pricing against listed pharma peers' valuations. The pure OFS structure (no fresh capital raise) means proceeds don't strengthen the company's balance sheet—watch opening premium sustainability.
HRS Aluglaze closes today with ₹96 upper price band and ₹2,30,400 minimum application (lot size: 1,200 shares) for BSE SME listing. The IPO opened December 11; allotment and listing dates to follow.
Park Medi World allotment finalizes today (December 15), with tentative listing scheduled for December 17 on BSE/NSE. The IPO closed on December 12.
• Nifty 50 Support: 25,750-25,700 | Resistance: 26,200-26,300
• Bank Nifty: Sustaining above 59,200 zone critical for momentum continuation
• Volatility Alert: Tech sector underperformance may continue following global cues
• China Economic Data: November retail sales, fixed asset investment, industrial production
• FII/DII Flows: Watch for continuation of institutional divergence patterns
• Currency: Rupee pressure zone around ₹90.40 levels versus dollar
• IT Stocks: Potential pressure following Nasdaq selloff and Broadcom concerns
• IPO Listings: Corona Remedies, Prodocs Solutions debut performance
• Pharma, FMCG: Defensive rotation candidates amid tech uncertainty
Week 50 data showed Nifty Auto leading gains at +0.8%, Nifty IT up 0.47%, while Nifty Pharma remained range-bound. Broader indices—Nifty Midcap 100 at 60,283.30 (+1.2% weekly) and Nifty Smallcap 250 at 16,396.85 (+0.8%)—outperformed benchmarks, indicating selective buying in mid and smallcap segments.
"Friday's moves underscored the potential that we could see the AI bubble burst at some point in the near future. We have seen good growth for Asian markets on the back of AI in particular and tech in general over the last year."
— Nick Twidale, Chief Market Analyst, AT Global Markets (December 15, 2025)
This analysis is for educational purposes only. Markets are subject to risks and uncertainties. Please consult your financial advisor before making investment decisions. Past performance is not indicative of future results.
www.oorjita.ai is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.oorjita.ai represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Oorjita Fin AI Services be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.oorjita.ai, or relating to the use of, or inability to use, www.oorjita.ai or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.
Oorjita FinAI Services | www.oorjita.ai | insights@oorjita.ai
Whatever trends you're following today: hope you're early enough to profit and wise enough to exit.
Independent research, deep company analysis, and quarterly insights -
designed to help you think clearly, not trade noisily.







